Sponsor pipeline

Ray Therapeutics, Inc. clinical trial pipeline

Get alerts when Ray Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1
Phase 1/2
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT07439887 Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal… Stargardt Disease Recruiting 2026-04-15
Phase 1
NCT06460844 Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia… Retinitis Pigmentosa Active, Not Recruiting 2026-02-20
Not specified
NCT07502664 Development and Evaluation of Functional Visual Field and Navigation Endpoints in… Retinitis Pigmentosa Recruiting 2026-03-31
NCT06375239 Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties… Retinitis Pigmentosa Recruiting 2025-01-08
Get alerts when Ray Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free